Fluvac Innovator 5

Manufacturer: Zoetis

Encephalomyelitis-rhinopneumonitis-influenza Vaccine

Eastern and Western, Killed Virus

Tetanus Toxoid

Fluvac Innovator 5 Indications

For vaccination of healthy horses as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses, equine rhinopneumonitis due to type 1 and 4 viruses, equine influenza due to type A₂ viruses, and tetanus.

Fluvac Innovator 5 Dosage And Administration

Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.

Fluvac Innovator 5 Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

For Veterinary Use Only

Remove Serial Number And Expiration Date Label And Place On The Animal’s Medical Chart.

Pfizer Animal Health, Exton, Pa 19341, Usa

Div. Of Pfizer Inc, Ny, Ny 10017

U.S. Vet. License No. 189

1 mL	1 Dose	7985P 12152600
10 mL	10 Doses	7985P 12152600

Nac No.

36902861